Knights of Columbus Asset Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,553
Closed -$601K 422
2024
Q1
$601K Sell
4,553
-212
-4% -$26.5K 0.04% 264
2023
Q4
$580K Sell
4,765
-70
-1% -$7.81K 0.04% 277
2023
Q3
$543K Buy
4,835
+2,203
+84% +$280K 0.05% 266
2023
Q2
$383K Buy
2,632
+2,197
+505% +$299K 0.03% 286
2023
Q1
$56.2K Buy
+435
New +$54.6K 0.01% 349
2020
Q4
Sell
-33,967
Closed -$4.49M 337
2020
Q3
$4.49M Sell
33,967
-33,387
-50% -$4.36M 0.56% 42
2020
Q2
$7.8M Buy
67,354
+9,545
+17% +$1.1M 0.96% 12
2020
Q1
$5.67M Sell
57,809
-28,290
-33% -$3.71M 0.72% 21
2019
Q4
$12.5M Buy
86,099
+64,211
+293% +$8.86M 1.1% 8
2019
Q3
$2.92M Hold
21,888
1.11% 32
2019
Q2
$2.5M Buy
21,888
+3,708
+20% +$434K 0.99% 37
2019
Q1
$2.25M Buy
18,180
+3,708
+26% +$421K 0.91% 41
2018
Q4
$1.46M Buy
+14,472
New +$1.63M 0.67% 55

Other funds holding ZBH

Knights of Columbus Asset Advisors's ZBH Position: Q2 2024 in Review

Knights of Columbus Asset Advisors sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 4,553 shares — an estimated $601K sold.

Knights of Columbus Asset Advisors first reported a position in ZBH in Q4 2018 and held it in 13 quarters. The position peaked at $12.5M in Q4 2019. 1,007 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Knights of Columbus Asset Advisors reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 4,553 Zimmer Biomet shares in Q2 2024, an estimated $601K.
  • Knights of Columbus Asset Advisors first reported a position in Zimmer Biomet in Q4 2018 and held it in 13 quarters.
  • Knights of Columbus Asset Advisors's Zimmer Biomet position peaked at $12.5M in Q4 2019.
  • 1,007 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.